Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 19 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 19 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Infographic – What is Crispr?

Crispr explainer

(CB Insights)

9 Feb. 2019. One hot topic we’ve covered almost from the beginning at Science & Enterprise is Crispr — clustered, regularly interspaced short palindromic repeats — a genome editing technique derived from bacterial defense systems. Our first story about the technique dates back to August 2013, but we were also among the early chroniclers of financing for start-up companies commercializing Crispr like Editas Medicine and Crispr Therapeutics, now in full swing developing treatments and licensing their technologies.

Even as Crispr has gained commercial traction and public attention, there’s still a need for a good illustrated introduction to the technique, which or friends at CB Insights published on Thursday, our infographic for this weekend. The chart is part of a larger report on the state of Crispr technology and its applications. Listed below are links to some of our recent stories on Crispr.

More from Science & Enterprise:

*     *     *

1 comment to Infographic – What is Crispr?